The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer: a simple, economical, and effective biomarker.

The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer: a simple, economical, and effective biomarker. J Thorac Dis. 2019 Mar;11(Suppl 3):S241-S244 Authors: Hamanaka K, Miura K, Koyama T, Matsuoka S, Takeda T, Yamada K, Hyogotani A PMID: 30997187 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research